Version 5.4
Mus musculus Protein: Prrg2
Summary
InnateDB Protein IDBP-181359.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Prrg2
Protein Name proline-rich Gla (G-carboxyglutamic acid) polypeptide 2
Synonyms 1600014G02Rik; 2510041M06Rik; N4WBP1;
Species Mus musculus
Ensembl Protein ENSMUSP00000007981
InnateDB Gene IDBG-181357 (Prrg2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 2 [view]
Protein-Protein 2 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005509 calcium ion binding
GO:0005515 protein binding
Biological Process
GO:0008150 biological_process
Cellular Component
GO:0005576 extracellular region
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:1929596
InterPro IPR000294 Gamma-carboxyglutamic acid-rich (GLA) domain
PFAM PF00594
PRINTS PR00001
PIRSF
SMART SM00069
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8R182
PhosphoSite PhosphoSite-Q8R182
TrEMBL D3Z4X3
UniProt Splice Variant
Entrez Gene 65116
UniGene Mm.379098
RefSeq NP_075375
MGI ID
MGI Symbol Prrg2
OMIM
CCDS CCDS21227
HPRD
IMGT
EMBL AC126256 AF220205 BC025098
GenPept AAG44244 AAH25098

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca